Latin America Cardiovascular Ultrasound Market 2022-2028

Latin America Cardiovascular Ultrasound Market 2022-2028

MARKET OUTLOOK

The cardiovascular ultrasound market in Latin America is predicted to showcase growth, with a CAGR of 6.41% during the forecast years between 2022 and 2028, according to a report by Triton Market Research. Mexico, Brazil, and Rest of Latin America are included in the market in this region.

Cardiovascular disease (CVD) incidence in the Mexican population is growing. In fact, cardiovascular disease mortality, as well as the prevalence of risk factors associated with the disease, have become significant causes of concern in Mexico. Thus, cardiovascular diseases and other non-communicable chronic diseases are becoming a growing burden as well as leading causes of disability among young adults.

The growing disease burden demands immediate attention, and the use of ultrasound systems for cardiovascular disease diagnosis will aid patients in seeking timely treatment. This, in turn, will foster the considered market’s growth. Even in Brazil, CVDs are a serious public health issue, as they are among the leading reasons for disability and mortality among adults, accounting for nearly 27.7% of total deaths.

The rising incidence of these diseases has a massive economic impact on the nation, leading to lost potential years of life and becoming a major burden on the public healthcare system, mainly in terms of expenditure. This makes it important to detect diseases on time, which can be done with the help of echocardiography systems. The adoption of these devices will aid the growth of the market in Brazil in the coming years.

COMPETITIVE OUTLOOK

The distinguished players operating in the cardiovascular ultrasound market include Viatom Technology Co, Lanmage, Fujifilm Holdings Corporation, Telemed Ultrasound Medical Systems, Samsung Medison Co Ltd, Dawei Medical, Mindray Medical International Limited, and Philips Healthcare.